Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Regulatory News (CSRT)

  • There is currently no data for CSRT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Invesco Ltd.: Form 8.3 - OPD Consort Medical PLC

19 Nov 2019 13:27



Invesco Ltd.: Form 8.3 - OPD Consort Medical PLC

FORM 8.3 OPD

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser: Invesco Ltd.
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree  Consort Medical PLC
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure  18 November 2019
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”  No

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:  10p ordinary GB0000946276
,  InterestsShort positions
 Number %Number %
(1) Relevant securities owned and/or controlled: 2,322,782 4.70%   
(2) Cash-settled derivatives:        
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:       
TOTAL: 2,322,782 4.70%   

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(73) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:  
Details, including nature of the rights concerned and relevant percentages:  

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1©, copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security Purchase/sale  Number of securities Price per unit
       

 (b) Cash-settled derivative transactions

Class of relevant security Product descriptione.g. CFD Nature of dealinge.g. opening/closing a long/short position, increasing/reducing a long/short position Number of reference securities Price per unit
         

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Typee.g. American, European etc. Expiry date Option money paid/ received per unit
               

(ii) Exercise

Class of relevant security Product descriptione.g. call option Exercising/ exercised against Number of securities Exercise price per unit
        

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealinge.g. subscription, conversion Details Price per unit (if applicable)
       

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:If there are no such agreements, arrangements or understandings, state “none”
None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? NO

Date of disclosure: 19 November 2019
Contact name: Philippa Holmes
Telephone number: 01491 417 447

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.


Date   Source Headline
2nd Mar 20201:50 pmRNSTotal Voting Rights
20th Feb 20207:15 amRNSDespatch of formal compulsory acquisition notices
17th Feb 20204:24 pmRNSCompulsory acquisition of Consort Shares
6th Feb 20205:00 pmRNSNotice of Cancellation of Listing
6th Feb 20204:31 pmRNSDirector/PDMR Shareholding
6th Feb 20201:30 pmRNSHolding(s) in Company
5th Feb 20205:30 pmRNSConsort Medical
5th Feb 20204:51 pmRNSHolding(s) in Company
5th Feb 20204:00 pmRNSForm 8.3 - Consort Medical Plc
5th Feb 20203:15 pmBUSFORM 8.3 - CONSORT MEDICAL PLC
5th Feb 202011:42 amBUSForm 8.3 - CONSORT MEDICAL PLC
5th Feb 202011:32 amRNSForm 8.5 (EPT/RI)
5th Feb 20205:00 amGNWForm 8.5 (EPT/RI) - Consort Medical plc
4th Feb 20204:19 pmRNSOffer declared Wholly Unconditional
4th Feb 20203:38 pmBUSForm 8.3 - Consort Medical plc
4th Feb 20203:34 pmRNSForm 8.3 - Consort Medical plc
4th Feb 20203:25 pmBUSForm 8.3 - Consort Medical plc
4th Feb 20203:07 pmRNSForm 8.3 - Consort Medical Plc
4th Feb 20203:00 pmRNSForm 8.3 - Consort Medical Plc
4th Feb 202012:10 pmBUSForm 8.3 - Consort Medical Plc
4th Feb 202011:24 amRNSForm 8.5 (EPT/RI)
4th Feb 202011:08 amRNSForm 8.3 - CONSORT MEDICAL PLC
4th Feb 20209:20 amGNWForm 8.5 (EPT/RI) - Consort Medical plc
4th Feb 20207:25 amBUSForm 8.3 - Consort Medical Plc
3rd Feb 20204:24 pmBUSFORM 8.3 - CONSORT MEDICAL PLC AMENDMENT
3rd Feb 20201:37 pmBUSForm 8.3 - Consort Medical Plc
3rd Feb 202012:43 pmBUSForm 8.3 - CONSORT MEDICAL PLC
3rd Feb 202012:00 pmRNSAdditional Listing
3rd Feb 202010:53 amRNSForm 8.5 (EPT/RI)
3rd Feb 20209:58 amGNWForm 8.5 (EPT/RI) - Consort Medical plc
31st Jan 20205:28 pmRNSForm 8.3 - [Consort Medical plc]
31st Jan 20202:56 pmBUSForm 8.3 - CONSORT MEDICAL PLC
31st Jan 202010:57 amRNSForm 8.5 (EPT/RI)
31st Jan 20209:16 amGNWForm 8.5 (EPT/RI) - Consort Medical Plc
30th Jan 20203:25 pmBUSForm 8.3 - Consort Medical plc
30th Jan 20202:34 pmBUSForm 8.3 - CONSORT MEDICAL PLC
30th Jan 20201:30 pmBUSForm 8.3 - CONSORT MEDICAL PLC
30th Jan 20201:18 pmRNSForm 8.3 - Consort Medical plc
30th Jan 202010:34 amRNSForm 8.5 (EPT/RI)
30th Jan 20209:18 amRNSForm 8.3 - Consort Medical plc
30th Jan 20208:50 amGNWForm 8.5 (EPT/RI) - Consort Medical plc
29th Jan 20204:21 pmRNSHolding(s) in Company
29th Jan 20201:18 pmBUSForm 8.3 - Consort Medical Plc
29th Jan 202011:50 amRNSForm 8.3 - Consort Medical PLC
29th Jan 202011:19 amRNSForm 8.5 (EPT/RI)
29th Jan 202010:41 amRNSResponse to Recipharm Statement
29th Jan 20209:45 amRNSHolding(s) in Company
29th Jan 20207:00 amRNSNo Extension or Increase & Irish CCPC Clearance
28th Jan 20203:25 pmBUSForm 8.3 - Consort Medical plc
28th Jan 20201:59 pmRNSForm 8.3 - Consort Medical Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.